KulkarniJA, WitzigmannD, ThomsonSB, et al. (2021). The current landscape of nucleic acid therapeutics. Nat. Nanotechnol., 2021; 16(6):630–643. doi:10.1038/s41565-021-00898-0.
2.
SunX, SetrerrahmaneS, LiC, HuJ, XuH. Nucleic acid drugs: recent progress and future perspectives. Signal Transduct Target Ther. 2024; 9:316. doi:10.1038/s41392-024-02035-4.
3.
AnkeS, JörgV. RNA-based medicine: from molecular mechanisms to therapy. EMBO J. 2023; 42(9):e114760. doi:10.15252/embj.2023114760.
4.
WeiY, QuanL, ZhouC, ZhanQ. Factors relating to the biodistribution and clearance of nanoparticles and their effects on in vivo application. Nanomedicine (Lond). 2018; 13(13):1495–1512. doi:10.2217/nnm-2018-0040.
5.
KarekarN, CahnAR, Morla-FolchJ, et al.Protocol for the development of mRNA lipid nanoparticle vaccines and analysis of immunization efficiency in mice. STAR Protoc. 2024; 5(2):103087. doi:10.1016/j.xpro.2024.103087.
6.
ChinnarajM, HuangH, HutchinsonS, et al.Protein barcoding and next-generation protein sequencing for multiplexed protein selection, analysis, and tracking. bioRxiv. Published online 2024. doi:10.1101/2024.12.31.630920.
7.
KumanoS, TanakaK, AkahoriR, YanagiyaA, NojimaA. Using peptide barcodes for simultaneous profiling of protein expression from mRNA. Rapid Commun Mass Spectrom. 2024; 38(6):e9867. doi:10.1002/rcm.9867.
